Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2012
11/28/2012CN101948512B Polypeptide WA8 for inhibiting type-2 shiga toxin activity and coding gene and application thereof
11/28/2012CN101641372B Template-fixed peptidomimetics
11/28/2012CN101624419B Group of novel uncyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof
11/28/2012CN101538315B Method for preparing Leuprorelin by combination of solid phase method and liquid phase method
11/27/2012US8318670 Antigens targeted by pathogenic AI4 T cells in type 1 diabetes and uses thereof
11/27/2012US8318659 Peptide-based organic sunscreens
11/27/2012US8318640 Methods for selective targeting
11/27/2012CA2527640C Tumor antigens for prevention and/or treatment of cancer
11/27/2012CA2516458C Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012157674A1 Cyclic peptide compound or pharmacologically acceptable salt thereof, method for producing cyclic peptide compound or pharmacologically acceptable salt thereof, and use of cyclic peptide compound or pharmacologically acceptable salt thereof
11/22/2012WO2012156743A1 Therapeutic fusion proteins
11/22/2012WO2012156511A1 Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents
11/22/2012WO2012126441A3 Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
11/22/2012WO2012041261A3 Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition
11/22/2012WO2011095705A3 Novel caspase-14 activator peptides and compositions comprising said peptides
11/22/2012US20120295990 Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay
11/22/2012US20120295842 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/22/2012US20120295280 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
11/22/2012US20120294924 Peptide-Lipid Conjugates And Uses Thereof
11/22/2012US20120294902 Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope
11/22/2012US20120294879 Consensus sequence for influenza a virus
11/22/2012US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/22/2012US20120294850 Ganglioside Epitopes For Treating Guillain-Barre Syndrome
11/22/2012US20120294801 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
11/22/2012CA2836573A1 Improved peptide pharmaceuticals
11/22/2012CA2835285A1 Therapeutic fusion proteins
11/21/2012EP2523968A1 Cyclic peptides for the regulation of vectorial ion channels
11/21/2012EP2523967A1 Novel anti-ageing peptides modulating survivin and compositions including same
11/21/2012CN102786583A Rana kunyuensis kunyuenin kunyuenin-3 as well as preparation method and application of rana kunyuensis kunyuenin kunyuenin-3
11/21/2012CN102786582A Tem8 peptides and vaccines comprising the same
11/21/2012CN102786581A Brevibacillus laterosporus antibacterial peptide and application of Brevibacillus laterosporus antibacterial peptide in pathogenic fungus inhibition and bacterium growth
11/21/2012CN102219830B Oxidation resisting polypeptide and preparation method thereof
11/21/2012CN102060910B HLA (Human Leukocyte Antigen)-A*0201 limitation CTL (Cytotoxic T Lymphocyte) epitope of zinc translocator and application thereof
11/21/2012CN102030819B Broad spectrum polypeptin and application thereof
11/21/2012CN102030817B Peptide for inhibiting angiontensin converting enzyme
11/21/2012CN101974071B Insulin B chain HLA-A*0201 restrictive CTL epitope modified peptide ligand and acquisition method and application thereof
11/21/2012CN101921314B Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease and preparation method
11/21/2012CN101914139B Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof
11/21/2012CN101899094B Preparation method of high-purity Daptomycin
11/21/2012CN101775067B New synthesized antibacterial peptide as well as preparation method and application thereof
11/21/2012CN101659693B Method for preparing pneumocandin B0
11/20/2012US8314208 Microwave enhanced N-fmoc deprotection in peptide synthesis
11/20/2012US8314141 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/20/2012US8314065 Method of reduction of wrinkles on skin or acceleration of wound healing by applying peptides related to basic fibroblast growth factor (bFGF)
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2421580C Discrimination between gnrh-i and gnrh-ii
11/20/2012CA2376978C Compositions and methods for treatment of sexual dysfunction
11/15/2012WO2012155124A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012WO2012155114A1 Peptides derived from uroguanylin and their use in gastrointestinal disorders
11/15/2012WO2012155107A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
11/15/2012WO2012154959A1 Peptide tyrosinase inhibitors and uses thereof
11/15/2012WO2012154368A1 Precipatable peptipes
11/15/2012WO2012154109A1 Self -aggregating antimicrobial cyclic peptides comprising beta - tri substituted amino acid residues
11/15/2012WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell
11/15/2012WO2012152225A1 Preparation method of micafungin sodium
11/15/2012WO2012152063A1 Novel biomarker of hcc, rarres2
11/15/2012US20120289681 Conjugates of cell-penetrating peptides and phosphorescent metalloporphyrins for intracellular oxygen measurement
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012US20120289461 Protein synthesis promoter
11/15/2012US20120289459 Antiviral peptides from african swine fever virus which prevent the binding of the virus to dlc8
11/15/2012US20120289454 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012US20120288514 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/15/2012US20120288513 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
11/15/2012US20120288447 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/15/2012CA2835627A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
11/14/2012CN102781953A Oligopeptidic compounds and uses thereof
11/14/2012CN102776264A TNF-alpha short peptide related to apoptosis or necrosis and application thereof
11/14/2012CN102775477A Method for improving sulfuric acid colistin after-extraction resin adsorption liquid quality
11/14/2012CN102775476A Preparation method of micafungin sodium
11/14/2012CN102775475A Method for purifying terlipressin acetate
11/14/2012CN102775474A Polypeptide and applications thereof
11/14/2012CN102775473A B cell epitope peptide of human neutrophil gelatinase associated lipocalin and application thereof
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775471A Method for synthesizing cholecystokinin octapeptide by combining solid phase method and liquid phase method
11/14/2012CN102775470A Short peptide for inhibiting human hepatitis B virus infection and its application
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102127153B Caco-2 cell surface specific binding polypeptide and screening method thereof
11/14/2012CN102060912B Amyloid protein oligomer conformation type epitope polypeptide and application thereof
11/14/2012CN102060911B Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
11/14/2012CN101679518B The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
11/14/2012CN101238142B Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
11/13/2012US8309687 Biomarker specific for cancer
11/13/2012US8309512 Platelet aggregation inhibitor composition
11/13/2012CA2615896C Macrocyclic peptides as hcv ns3 protease inhibitors
11/13/2012CA2487061C Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
11/08/2012WO2012150475A1 Synthetic composition and coating for cell culture.
11/08/2012WO2012149644A1 Novel agonists and antagonists of the urotensinergic system
11/08/2012US20120283411 Methods and compositions for the treatment of gastrointestinal disorders
11/08/2012US20120283410 Attachment of biological targeting groups using metal free click chemistry
11/08/2012US20120283196 Beta-hairpin peptidomimetics
11/08/2012US20120283194 Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120283182 Peptide Modulators of the deltaPKC Interaction with the d Subunit of F1F0 ATP Synthase/ATPase and Uses Thereof
11/08/2012US20120283176 Short fatty acid tail polymyxin derivatives and uses thereof
11/08/2012US20120283173 Novel compositions for treating pseudomonas infection
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282286 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 423